ONCOZENGE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.3 SEK | -2.22% |
|
-1.35% | +6.80% |
| May. 21 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOZENGE AB | Other Pharmaceuticals | -2.22% | -1.35% | +6.80% | -44.82% | - | 3.79M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ONCOZ Stock
- Charts OncoZenge AB
- Comparison Chart
